CD8A and glioblastoma: This study describes such strategy using a computational approach for the identification of GBM patients harboring high-quality neoantigens that, together with CD8+ T lymphocyte infiltrates, perform optimally in identifying patients with the longest survival and a functionally activated tumor immune microenvironment.